Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9DWR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,031
Award facts
- Contract value 100% obligated
- $12,030.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 28, 2026, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $12,030.55, is scheduled for completion by January 29, 2026, with performance to be executed at the awardee's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the company's capability to meet federal procurement requirements through open competition.
This delivery order is issued under AmerSourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical supply agreement valued at up to $999,999,999.00 and extending through December 2026. This prime IDC serves as a global pharmaceutical support vehicle enabling AmerSourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide, including serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current order for RINVOQ ER (baricitinib extended-release), used in the treatment of rheumatoid arthritis and other inflammatory conditions, exemplifies the diverse pharmaceutical portfolio delivered through this strategic contract vehicle.
Quick answers
Who was awarded contract SPE2DR26F9DWR?
SPE2DR26F9DWR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F9DWR worth?
The government has obligated $12,031 on SPE2DR26F9DWR.
Is contract SPE2DR26F9DWR an order under another contract?
Yes. SPE2DR26F9DWR is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DWR competed?
The extent of competition for SPE2DR26F9DWR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award